Form 4 for LLY Lilly (Eli)
Accepted 2023-02-03 00:00:00 ET · period of report 2023-02-01 · accession 0000059478-23-000043 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-03 | 2023-02-01 | LLY | White Anne E. | EVP, Pres, Lilly Neuroscience | F - Tax | $344.15 | -3,252 | 54.4K | -6% | -$1.12M |
| D | 2023-02-03 | 2023-02-01 | LLY | White Anne E. | EVP, Pres, Lilly Neuroscience | M - OptEx | $0.00 | +7,264 | 57.6K | +14% | $0 |
| D | 2023-02-03 | 2023-02-01 | LLY | White Anne E. | EVP, Pres, Lilly Neuroscience | M - OptEx | $0.00 | -7,264 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-01 | F | D | 3,252 | $344.15 | 54,364 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-01 | M | A | 7,264 | $0.00 | 57,616 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2023-02-01 | M | D | 7,264 | $0.00 | 0 | D | — · 2023-02-01 to 2023-02-01 | 7,264 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |